Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

DNA methylation is essential for skin and hair follicle development, and could be a target for treating skin diseases.

C/EBPalpha and C/EBPbeta are crucial for normal skin and oil gland cell development in adult mice.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

A woman with lupus had blood cell destruction, treated successfully with medication.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Placental growth factor may help treat hair loss.

TLR4 is important in aging-related diseases and could be a new treatment target.

Fibroblasts and myeloid cells in mouse skin wounds are diverse and can change into different cell types during healing.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Myeloid cells can turn into skin and hair cells to help heal wounds.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.